Osiris Therapeutics competitorsClear all

Osiris Therapeutics's top competitors include ACell, Touchlight Genetics, Personal Genome Diagnostics (PGD) and Blueprint Genetics.

Save Comparison	Osiris Therapeutics Osiris Therapeutics is a company that researches, develops, manufactures, markets, and distributes regenerative medicine products.	ACell ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.	Touchlight Genetics Touchlight Genetics Ltd is a biotechnology company operating in the field of DNA therapies and DNA technology.	Personal Genome Diagnostics (PGD) Personal Genome Diagnostics Inc. develops patient-specific analysis of the cancer genome by using advanced tools and technologies.	Blueprint Genetics Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services.
Founding Date	Founding Date 1992	Founding Date 2002	Founding Date 2008	Founding Date 2010	Founding Date 2012
Type	Type Subsidiary	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech genetics	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Columbia, US HQ	Locations Columbia, US HQ Lafayette, US	Locations London, GB HQ Hampton, GB	Locations Baltimore, US HQ	Locations Esbo, FI HQ Dubai, AE Seattle, US
Employees	Employees 2443% decrease	Employees 400	Employees 797% increase	Employees 118	Employees 1841% increase
Twitter followers	Twitter followers N/A	Twitter followers N/A	Twitter followers N/A	Twitter followers 591	Twitter followers 4.1 k
Alexa Website Rank	Alexa Website Rank 265213	Alexa Website Rank 241232	Alexa Website Rank 618980	Alexa Website Rank 204161	Alexa Website Rank 314437
Employee Rating	Employee Rating 2.4	Employee Rating 3.9	Employee Rating N/A	Employee Rating 2.4	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) $142.8m (FY, 2018)	Revenue (est.) $100.8m (FY, 2019)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $38.1m (FY, 2018)	Cost of goods $19.1m (FY, 2019)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $104.7m (FY, 2018)	Gross profit $81.7m (FY, 2019)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income $36.9m (FY, 2018)	Net income $1.4m (FY, 2019)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 65m	Total funding raised $ 8.7m	Total funding raised N/A	Total funding raised $ 141.3m	Total funding raised $ 26.3m